FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


23369 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Humerus X-ray Plain X-ray of humerus (procedure)
Humid environment Humid environment (finding)
Humulin insulin adverse reaction Adverse reaction caused by human insulin (disorder)
Husband of subject Husband
Hyaline membrane disease Respiratory distress syndrome in the newborn
Hyaluronidase 1500unt/10mL injection Product containing precisely bovine hyaluronidase 150 unit/1 milliliter conventional release solution for injection (clinical drug)
Hyaluronidase 150unt/mL injection solution 10mL vial Product containing precisely bovine hyaluronidase 150 unit/1 milliliter conventional release solution for injection (clinical drug)
Hyaluronidase 150unt/mL injection solution 1mL vial Product containing precisely bovine hyaluronidase 150 unit/1 milliliter conventional release solution for injection (clinical drug)
Hydatidiform mole, no International Classification of Diseases for Oncology subtype Hydatidiform mole, benign (morphologic abnormality)
Hydralazine hydrochloride 20mg injection powder vial Hydralazine hydrochloride 20 mg powder for solution for injection vial
Hydrazide antituberculosis agent Antituberculosis agent
Hydrazide antituberculosis drug adverse reaction Isoniazid adverse reaction
Hydrocephalic disproportion NOS Hydrocephalic disproportion
Hydrocephalic disproportion unspecified Hydrocephalic disproportion
Hydrocephalic disproportion with antenatal problem Hydrocephalic disproportion
Hydrochlorothiazide + quinapril hydrochloride Product containing hydrochlorothiazide and quinapril (medicinal product)
Hydrochlorothiazide + quinapril hydrochloride 12.5mg/10mg tablet Hydrochlorothiazide 12.5 mg and quinapril (as quinapril hydrochloride) 10 mg oral tablet
Hydrochlorothiazide 25mg Hydrochlorothiazide 25 mg oral tablet
Hydrocortisone 1% + Pramocaine 1% conventional release rectal foam Hydrocortisone and pramocaine only product
Hydrocortisone 1% + Pramocaine 1% foam enema Hydrocortisone and pramocaine only product
Hydrocortisone 100mg powder and solvent for injection solution vial Hydrocortisone (as hydrocortisone sodium succinate) 100 mg powder for solution for injection vial
Hydrocortisone 100mg/60mL Product containing precisely hydrocortisone 1.67 milligram/1 milliliter conventional release rectal suspension (clinical drug)
Hydrocortisone 100mg/60mL enema Product containing precisely hydrocortisone 1.67 milligram/1 milliliter conventional release rectal suspension (clinical drug)
Hydrocortisone 2% topical lotion Hydrocortisone acetate 20 mg/mL cutaneous lotion
Hydrocortisone acetate 1% eye drops Hydrocortisone 10 mg/mL eye solution
Hydrocortisone acetate 2.5% cream Product containing precisely hydrocortisone 25 milligram/1 milliliter conventional release cutaneous cream (clinical drug)
Hydrocortisone acetate+neomycin sulfate 1.5%/0.5% eye drops Hydrocortisone acetate 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL eye solution
Hydrocortisone cypionate 10mg/5mL suspension Product containing precisely hydrocortisone 2 milligram/1 milliliter conventional release oral suspension (clinical drug)
Hydrocortisone/neomycin cream Hydrocortisone acetate 10 mg/g and neomycin sulfate 5 mg/g cutaneous cream
Hydrolyase Hydrolyase
Hydromorphone hydrochloride 100% powder Hydromorphone only product
Hydromorphone hydrochloride 12mg m/r capsule Product containing only hydromorphone in oral dose form (medicinal product form)
Hydromorphone hydrochloride 12mg prolonged-release oral capsule Product containing only hydromorphone in oral dose form (medicinal product form)
Hydromorphone hydrochloride 1mg/mL injection solution ampule Hydromorphone hydrochloride 1 mg/mL solution for injection
Hydromorphone hydrochloride 32mg m/r capsule Product containing only hydromorphone in oral dose form (medicinal product form)
Hydromorphone hydrochloride 32mg prolonged-release oral capsule Product containing only hydromorphone in oral dose form (medicinal product form)
Hydromorphone hydrochloride 4mg/mL injection solution ampule Hydromorphone hydrochloride 4 mg/mL solution for injection
Hydrotherapy NOS Hydrotherapy
Hydrotherapy NOS Hydrotherapy
Hydrous wool fat+zinc oxide 4/8% conventional release cutaneous cream Lanolin and zinc oxide only product in cutaneous dose form
Hydrous wool fat+zinc oxide 4/8% cream Lanolin and zinc oxide only product in cutaneous dose form
Hydroxocobalamin 1mg/mL injection 1mL ampule Product containing precisely hydroxocobalamin (as hydroxocobalamin acetate) 1 milligram/1 milliliter conventional release solution for injection (clinical drug)
Hydroxocobalamin 2.5g powder for conventional release solution for injection vial Product containing only hydroxocobalamin in parenteral dose form (medicinal product form)
Hydroxocobalamin 2.5g powder for injection solution vial + diluent Product containing only hydroxocobalamin in parenteral dose form (medicinal product form)
Hydroxyethylcellulose 0.44% conventional release eye drops Product containing only hyetellose (medicinal product)
Hydroxyethylcellulose 0.44% single-use eye drops Product containing only hyetellose (medicinal product)
Hydroxypropyl methylcellulose 0.32% conventional release eye drops Hypromellose 3.2 mg/mL eye solution
Hydroxypropyl methylcellulose 0.32% single-use eye drops Hypromellose 3.2 mg/mL eye solution
Hydroxypropylmethylcellulose 2% eye drops Product containing precisely hypromellose 2 milligram/1 milliliter conventional release eye solution (clinical drug)
Hymenoptera species Order Hymenoptera (organism)
Hyoscine butylbromide allergy Allergy to hyoscine
Hyoscine hydrobromide 0.125% eye drops Hyoscine (as hyoscine hydrobromide) 1.25 mg/mL eye solution
Hyoscine hydrobromide 0.25% eye drops Product containing precisely scopolamine (as scopolamine hydrobromide) 2.5 milligram/1 milliliter conventional release eye solution (clinical drug)
Hyoscine hydrobromide 0.5% eye drops Hyoscine (as hyoscine hydrobromide) 5 mg/mL eye solution
Hyoscine hydrobromide allergy Allergy to hyoscine
Hyoscyamine sulfate 0.031mg/1 mL Hyoscyamine only product
Hyoscyamine sulfate 0.125mg/5mL elixir Hyoscyamine sulfate 25 microgram/mL oral solution
Hyoscyamine sulfate 0.125mg/5mL liquid Hyoscyamine sulfate 25 microgram/mL oral solution
Hyoscyamine sulfate 0.125mg/mL liquid Hyoscyamine sulfate 25 microgram/mL oral solution
Hyperalphaglobulinemia Hyperalphaglobulinaemia
Hyperbetaglobulinemia Hyperbetaglobulinemia
Hypercalcemia caused by thiazide AND vitamin A Hypercalcemia caused by thiazide and/or retinol (disorder)
Hyperchromia Hyperchromatism
Hypercupremia Blood copper level above reference range
Hypercupremia Blood copper level above reference range
Hyperglobulinemia Hyperglobulinemia
Hyperglycemia clinical management plan Hyperglycemia clinical management plan
Hyperglycemia self management plan Hyperglycemia self management plan
Hyperhidrosis, premature cavities and premolar aplasia Book syndrome (disorder)
Hyperinsulinemia due to benign insulinoma Hyperinsulinemia due to malignant insulinoma
Hyperinsulinemia due to insulinoma Hyperinsulinemia due to malignant insulinoma
Hyperlipidaemia NOS Hyperlipidemia
Hyperlipidemia NOS Hyperlipidemia
Hyperlipidemia clinical management plan Hyperlipidaemia clinical management plan
Hypermenorrhea Menorrhagia (finding)
Hypermobility Musculoskeletal hypermobility
Hyperpyrexia Hyperpyrexia (finding)
Hypersensitivity alveolitis in lungworm infection Hypersensitivity pneumonitis (disorder)
Hypersensitivity skin test NOS Hypersensitivity skin testing
Hypersensitivity skin test NOS Hypersensitivity skin testing
Hypersomnolence caused by substance Drug-induced hypersomnia
Hypertension clinical management plan Hypertension clinical management plan (record artifact)
Hypertension of pregnancy NOS Pregnancy-induced hypertension
Hypertension of pregnancy NOS Pregnancy-induced hypertension
Hypertensive disease NOS Hypertensive disorder, systemic arterial (disorder)
Hypertensive disease NOS Hypertensive disorder, systemic arterial (disorder)
Hypertensive ischemic ulcer Ischemic ulcer of skin due to arterial hypertension (disorder)
Hyperthermia in newborn, unspecified Hyperthermia in newborn
Hypertonic saline Sodium chloride only product
Hypertonic uterine inertia with antenatal problem Hypertonic uterine inertia
Hypertrichosis and acromegaloid facial appearance syndrome Cantu's syndrome
Hypertrichosis universalis Congenital hypertrichosis
Hypertrophic cardiomyopathy associated with another disorder Hypertrophic cardiomyopathy due to disorder
Hypertrophic cardiomyopathy secondary to Friedreich's ataxia Hypertrophic cardiomyopathy due to Friedreich ataxia
Hypertrophic cardiomyopathy secondary to hyperthyroidism Hypertrophic cardiomyopathy due to hyperthyroidism
Hypertrophic cardiomyopathy secondary to neuromuscular disorder Hypertrophic cardiomyopathy due to neuromuscular disorder
Hypertrophy of bone External hyperostosis
Hypertrophy of bone and cartilage External hyperostosis
Hypertrophy of cartilage Hypertrophy
Hypnotic Hypnotic agent (substance)
Hypnotic agent Hypnotic agent (substance)

Start Previous Page 87 of 234 Next End


Reference Sets

Reference set descriptor

Back to Start